Infect Chemother.
2024 Sep;56(3):406-408. 10.3947/ic.2024.0105.
Call for Balancing the Risks and Benefits of Immunotherapeutic Agents for Lymphoma during the COVID-19 Pandemic
- Affiliations
-
- 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
- KMID: 2559794
- DOI: http://doi.org/10.3947/ic.2024.0105
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Management of Thyroid Disease in COVID-19 Pandemic
- The effect of regional distribution of isolation rooms in emergency departments on ambulance travel time during the COVID-19 pandemic
- Assessment and Management of Dysphagia during the COVID-19 Pandemic
- Tracheostomy in the Era of COVID-19 Pandemic
- The COVID-19 pandemic's impact on prostate cancer screening and diagnosis in Korea
